This announcement is a separate document:
科伦药业：关于四川科伦药业股份有限公司2021年限制性股票激励计划第二个解除限售条件成就及回购注销部分限制性股票等相关事项的法律意见书
Sichuan Kelun Pharmaceutical: Legal opinion on matters relating to the fulfillment of the conditions for lifting sales restrictions and the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan of Sichuan Colon Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.